Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from InnoCare Pharma Ltd. ( (HK:9969) ).
InnoCare Pharma Ltd. has announced the composition of its board of directors and their roles in various committees. This update is significant as it reflects the company’s strategic leadership structure, which may influence its decision-making processes and governance, impacting stakeholders’ confidence in its corporate direction.
More about InnoCare Pharma Ltd.
InnoCare Pharma Ltd. operates in the pharmaceutical industry, focusing on the development and commercialization of drugs. The company is particularly active in creating therapies for cancer and autoimmune diseases.
YTD Price Performance: -7.84%
Average Trading Volume: 4,606,587
Technical Sentiment Consensus Rating: Buy
Current Market Cap: HK$8.44B
For detailed information about 9969 stock, go to TipRanks’ Stock Analysis page.